Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/MERCK-CO-INC-13611/noticia/Merck-anuncia-que-la-Comisi-n-Europea-aprueba-KEYTRUDA-pembrolizumab-m-s-quimioterapia-como-tr-40540114/?utm_source=whatsapp&utm_medium=social&utm_campaign=share